Spero Biopharma

Prevention and Treatment of Alzheimer's Disease

Health Tech & Life Sciences

Active

Pre-Funding Ramat HaSharon Founded 2019

Website ↗

Total raised

—

Stage

Pre-Funding

Founded

2019

Headcount

1-10

Ramat HaSharon

Sector

Health Tech & Life Sciences

About

Spero Biopharma is the developer of Ladostigil, a drug designed to treat mild cognitive impairment before it progresses to Alzheimer's disease.

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development

Technologies

Biologicals

Target customers

Healthcare & Life SciencesLife SciencesPharmaceuticals

Business model

B2B

1 Patents

Name	Spero Biopharma
Slug	spero-biopharma
Type	Israeli Startup
Founded	2019
HQ city	Ramat HaSharon
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object]
Business models	B2B
Target customers	[object Object], [object Object], [object Object]
Status	active
Current stage	Pre-Funding
Public stage	Pre-Funding
Total raised (USD)	0
Website	https://www.sperobio.com/
Crunchbase ID	spero-biopharma
Israeli Companies Registrar	516044435

Name	Role	LinkedIn
Moti Hacham
Marta Weinstock-Rosin